name,category,termsN-acetyltransferase 8 (GCN5-related, putative); N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene),INTERPRO[450000154$IPR000182:GCN5-related N-acetyltransferase, 450014522$IPR016181:Acyl-CoA N-acyltransferase]
N-acetyltransferase 8 (GCN5-related, putative); N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene),PIR_SUPERFAMILY[630021012$PIRSF027824:PIRSF027824]
N-acetyltransferase 8 (GCN5-related, putative); N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene),SP_PIR_KEYWORDS[790000025$Acyltransferase, 790000356$complete proteome, 790000428$developmental protein, 790000586$gastrulation, 790000919$membrane, 790001212$polymorphism, 790001547$transferase, 790001555$transmembrane]
N-acetyltransferase 8 (GCN5-related, putative); N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene),UP_SEQ_FEATURE[850042887$chain:Probable N-acetyltransferase 8, 850042888$chain:Probable N-acetyltransferase 8B, 850104817$domain:N-acetyltransferase, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
WW domain containing E3 ubiquitin protein ligase 1,COG_ONTOLOGY[90000102$RNA processing and modification]
WW domain containing E3 ubiquitin protein ligase 1,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450000485$IPR000569:HECT, 450001055$IPR001202:WW/Rsp5/WWP, 450016334$IPR018029:C2 membrane targeting protein]
WW domain containing E3 ubiquitin protein ligase 1,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis, 470038841$hsa04144:Endocytosis]
WW domain containing E3 ubiquitin protein ligase 1,PIR_SUPERFAMILY[630001740$PIRSF001569:E3 ubiquitin-protein ligase, Nedd4/Rsp5p types]
WW domain containing E3 ubiquitin protein ligase 1,SMART[760000104$SM00119:HECTc, 760000211$SM00239:C2, 760000401$SM00456:WW]
WW domain containing E3 ubiquitin protein ligase 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000733$host-virus interaction, 790000859$ligase, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001592$ubl conjugation, 790001593$ubl conjugation pathway]
WW domain containing E3 ubiquitin protein ligase 1,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850033801$chain:NEDD4-like E3 ubiquitin-protein ligase WWP1, 850103199$domain:C2, 850104105$domain:HECT, 850105732$domain:WW 1, 850105733$domain:WW 2, 850105734$domain:WW 3, 850105735$domain:WW 4, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850118545$site:Required for ubiquitin-thioester formation, 850118574$splice variant, 850118575$strand, 850118624$turn]
abhydrolase domain containing 8,INTERPRO[450000062$IPR000073:Alpha/beta hydrolase fold-1]
abhydrolase domain containing 8,SP_PIR_KEYWORDS[790000356$complete proteome, 790000743$hydrolase]
abhydrolase domain containing 8,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850003163$chain:Abhydrolase domain-containing protein 8, 850117294$sequence conflict]
adenylate cyclase 5,INTERPRO[450000923$IPR001054:Adenylyl cyclase class-3/4/guanylyl cyclase, 450008505$IPR009398:Adenylate cyclase-like, 450016581$IPR018297:Adenylyl cyclase class-3/4/guanylyl cyclase, conserved site]
adenylate cyclase 5,KEGG_PATHWAY[470038742$hsa00230:Purine metabolism, 470038831$hsa04062:Chemokine signaling pathway, 470038835$hsa04114:Oocyte meiosis, 470038845$hsa04270:Vascular smooth muscle contraction, 470038858$hsa04540:Gap junction, 470038883$hsa04912:GnRH signaling pathway, 470038884$hsa04914:Progesterone-mediated oocyte maturation, 470038885$hsa04916:Melanogenesis, 470038922$hsa05414:Dilated cardiomyopathy]
adenylate cyclase 5,PIR_SUPERFAMILY[630001609$PIRSF001445:adenylate cyclase]
adenylate cyclase 5,SMART[760000036$SM00044:CYCc]
adenylate cyclase 5,SP_PIR_KEYWORDS[790000138$atp-binding, 790000222$camp biosynthesis, 790000356$complete proteome, 790000616$glycoprotein, 790000891$lyase, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001304$repeat, 790001555$transmembrane]
adenylate cyclase 5,UP_SEQ_FEATURE[850003896$chain:Adenylate cyclase type 5, 850104091$domain:Guanylate cyclase 1, 850104092$domain:Guanylate cyclase 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106134$metal ion-binding site:Magnesium 1, 850106137$metal ion-binding site:Magnesium 2, 850106139$metal ion-binding site:Magnesium 2; via carbonyl oxygen, 850106258$modified residue, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
cell death-inducing DFFA-like effector b,INTERPRO[450003076$IPR003508:Caspase-activated nuclease CIDE-N]
cell death-inducing DFFA-like effector b,SMART[760000238$SM00266:CAD]
cell death-inducing DFFA-like effector b,SP_PIR_KEYWORDS[790000002$3d-structure, 790000109$Apoptosis, 790000356$complete proteome, 790001162$phosphoprotein]
cell death-inducing DFFA-like effector b,UP_SEQ_FEATURE[850010287$chain:Cell death activator CIDE-B, 850103367$domain:CIDE-N, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
chromosome 1 open reading frame 91,INTERPRO[450017180$IPR018908:Uncharacterised protein family UPF0546]
chromosome 1 open reading frame 91,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 1 open reading frame 91,UP_SEQ_FEATURE[850097717$chain:UPF0546 membrane protein C1orf91, 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
family with sequence similarity 40, member B,INTERPRO[450011166$IPR012486:N1221-like]
family with sequence similarity 40, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 40, member B,UP_SEQ_FEATURE[850045982$chain:Protein FAM40B, 850102576$compositionally biased region:Poly-Leu, 850117295$sequence variant, 850118574$splice variant]
fibronectin type III domain containing 5,INTERPRO[450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold]
fibronectin type III domain containing 5,SMART[760000051$SM00060:FN3]
fibronectin type III domain containing 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001128$peroxisome, 790001405$signal, 790001555$transmembrane]
fibronectin type III domain containing 5,UP_SEQ_FEATURE[850019441$chain:Fibronectin type III domain-containing protein 5, 850103799$domain:Fibronectin type-III, 850105770$glycosylation site:N-linked (GlcNAc...), 850117578$short sequence motif:Microbody targeting signal, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
iroquois homeobox 5,INTERPRO[450001200$IPR001356:Homeobox, 450003418$IPR003893:Iroquois-class homeodomain protein, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
iroquois homeobox 5,SMART[760000341$SM00389:HOX, 760000488$SM00548:IRO]
iroquois homeobox 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001377$sensory transduction, 790001622$vision, 790001628$vitamin d]
iroquois homeobox 5,UP_SEQ_FEATURE[850026829$chain:Iroquois-class homeodomain protein irx-5, 850102565$compositionally biased region:Poly-Ala, 850102572$compositionally biased region:Poly-Glu, 850102573$compositionally biased region:Poly-Gly, 850102580$compositionally biased region:Poly-Pro, 850102935$DNA-binding region:Homeobox; TALE-type, 850117294$sequence conflict]
kinesin family member 26B,INTERPRO[450001552$IPR001752:Kinesin, motor region, 450018052$IPR019821:Kinesin, motor region, conserved site]
kinesin family member 26B,SMART[760000111$SM00129:KISc]
kinesin family member 26B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000960$microtubule, 790000986$motor protein, 790001063$nucleotide-binding, 790001162$phosphoprotein]
kinesin family member 26B,UP_SEQ_FEATURE[850027489$chain:Kinesin-like protein KIF26B, 850102517$compositionally biased region:Gly-rich, 850102597$compositionally biased region:Ser-rich, 850104543$domain:Kinesin-motor, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850118574$splice variant]
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor),BIOCARTA[30000067$h_compPathway:Complement Pathway, 30000171$h_lectinPathway:Lectin Induced Complement Pathway]
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor),INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000373$IPR000436:Sushi/SCR/CCP, 450000750$IPR000859:CUB, 450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450001663$IPR001881:EGF-like calcium-binding, 450011699$IPR013032:EGF-like region, conserved site, 450014444$IPR016060:Complement control module, 450016397$IPR018097:EGF-like calcium-binding, conserved site, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site]
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor),KEGG_PATHWAY[470038859$hsa04610:Complement and coagulation cascades]
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor),PIR_SUPERFAMILY[630001305$PIRSF001155:complement-activating serine proteases C1r/C1s/MASP]
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor),SMART[760000013$SM00020:Tryp_SPc, 760000024$SM00032:CCP, 760000034$SM00042:CUB, 760000153$SM00179:EGF_CA]
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000144$autocatalytic cleavage, 790000176$beta-hydroxyasparagine, 790000211$calcium, 790000351$complement activation lectin pathway, 790000355$complement pathway, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000481$egf-like domain, 790000616$glycoprotein, 790000743$hydrolase, 790000745$hydroxylation, 790000763$immune response, 790000777$innate immunity, 790000885$liver, 790000937$metal-binding, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001363$Secreted, 790001383$Serine protease, 790001386$serine proteinase, 790001405$signal, 790001471$sushi]
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor),UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850030406$chain:Mannan-binding lectin serine protease 1, 850030407$chain:Mannan-binding lectin serine protease 1 heavy chain, 850030408$chain:Mannan-binding lectin serine protease 1 light chain, 850102883$disulfide bond, 850103433$domain:CUB 1, 850103444$domain:CUB 2, 850103705$domain:EGF-like; calcium-binding, 850104964$domain:Peptidase S1, 850105416$domain:Sushi 1, 850105429$domain:Sushi 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105910$metal ion-binding site:Calcium 1, 850105915$metal ion-binding site:Calcium 1; via carbonyl oxygen, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850105925$metal ion-binding site:Calcium 3, 850105927$metal ion-binding site:Calcium 3; via carbonyl oxygen, 850106258$modified residue, 850106259$mutagenesis site, 850111906$region of interest:Homodimerization, 850112325$region of interest:Interaction with FCN2, 850112521$region of interest:Interaction with MBL2, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118006$site:Cleavage; by autolysis, 850118574$splice variant, 850118575$strand, 850118624$turn]
mediator complex subunit 26,INTERPRO[450003177$IPR003617:Transcription elongation factor, TFIIS/CRSP70, N-terminal, sub-type, 450009997$IPR010990:Transcription elongation factor, TFIIS/elongin A/CRSP70, N-terminal, 450013215$IPR014765:Transcription elongation factor, TFIIS/CRSP70, N-terminal, 450016237$IPR017923:TFIIS N-terminal]
mediator complex subunit 26,SMART[760000452$SM00509:TFS2N]
mediator complex subunit 26,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
mediator complex subunit 26,UP_SEQ_FEATURE[850030757$chain:Mediator of RNA polymerase II transcription subunit 26, 850102586$compositionally biased region:Pro-rich, 850105477$domain:TFIIS N-terminal, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
myosin XVA,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region, 450000257$IPR000299:FERM domain, 450000748$IPR000857:Unconventional myosin/plant kinesin-like protein/non-motor protein conserved region MyTH4, 450001294$IPR001452:Src homology-3 domain, 450001427$IPR001609:Myosin head, motor region, 450010373$IPR011511:Variant SH3, 450017984$IPR019747:FERM conserved site, 450017985$IPR019748:FERM central domain, 450017986$IPR019749:Band 4.1 domain]
myosin XVA,OMIM_DISEASE[520001377$Deafness, autosomal recessive 3]
myosin XVA,SMART[760000009$SM00015:IQ, 760000121$SM00139:MyTH4, 760000214$SM00242:MYSc, 760000266$SM00295:B41, 760000295$SM00326:SH3]
myosin XVA,SP_PIR_KEYWORDS[790000019$actin-binding, 790000138$atp-binding, 790000218$calmodulin-binding, 790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000415$deafness, 790000446$disease mutation, 790000645$Hearing, 790000986$motor protein, 790001002$myosin, 790001041$non-syndromic deafness, 790001063$nucleotide-binding, 790001304$repeat, 790001398$sh3 domain]
myosin XVA,UP_SEQ_FEATURE[850033077$chain:Myosin-XV, 850103760$domain:FERM, 850104440$domain:IQ 1, 850104451$domain:IQ 2, 850104462$domain:IQ 3, 850104809$domain:Myosin head-like, 850104814$domain:MyTH4 1, 850104815$domain:MyTH4 2, 850105350$domain:SH3, 850106263$nucleotide phosphate-binding region:ATP, 850110834$region of interest:Actin-binding, 850113723$region of interest:Neck or regulatory domain, 850114844$region of interest:Tail, 850117295$sequence variant]
poly (ADP-ribose) polymerase family, member 12,INTERPRO[450000486$IPR000571:Zinc finger, CCCH-type, 450003680$IPR004170:WWE domain, 450011020$IPR012317:Poly(ADP-ribose) polymerase, catalytic region]
poly (ADP-ribose) polymerase family, member 12,SMART[760000324$SM00356:ZnF_C3H1]
poly (ADP-ribose) polymerase family, member 12,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000937$metal-binding, 790001006$nad, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
poly (ADP-ribose) polymerase family, member 12,UP_SEQ_FEATURE[850039711$chain:Poly [ADP-ribose] polymerase 12, 850102565$compositionally biased region:Poly-Ala, 850104895$domain:PARP catalytic, 850105737$domain:WWE 1, 850105738$domain:WWE 2, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn, 850118752$zinc finger region:C3H1-type 1, 850118753$zinc finger region:C3H1-type 2, 850118754$zinc finger region:C3H1-type 3, 850118756$zinc finger region:C3H1-type 4]
protein O-fucosyltransferase 2,INTERPRO[450017616$IPR019378:GDP-fucose protein O-fucosyltransferase]
protein O-fucosyltransferase 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000232$carbohydrate metabolism, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000570$Fucose metabolism, 790000616$glycoprotein, 790000619$glycosyltransferase, 790001405$signal, 790001547$transferase]
protein O-fucosyltransferase 2,UP_SEQ_FEATURE[850020734$chain:GDP-fucose protein O-fucosyltransferase 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide, 850118574$splice variant]
protein tyrosine phosphatase, non-receptor type 6,BIOCARTA[30000100$h_epoPathway:EPO Signaling Pathway, 30000125$h_ghPathway:Growth Hormone Signaling Pathway, 30000156$h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation, 30000157$h_il3Pathway:IL 3 signaling pathway, 30000202$h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity]
protein tyrosine phosphatase, non-receptor type 6,INTERPRO[450000210$IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450000852$IPR000980:SH2 motif, 450010930$IPR012152:Protein-tyrosine phosphatase, non-receptor type-6, -11, 450014489$IPR016130:Protein-tyrosine phosphatase, active site]
protein tyrosine phosphatase, non-receptor type 6,KEGG_PATHWAY[470038856$hsa04520:Adherens junction, 470038866$hsa04630:Jak-STAT signaling pathway, 470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038869$hsa04660:T cell receptor signaling pathway, 470038870$hsa04662:B cell receptor signaling pathway]
protein tyrosine phosphatase, non-receptor type 6,PIR_SUPERFAMILY[630001073$PIRSF000929:non-receptor tyrosine-protein phosphatase, 6/11 types, 630001074$PIRSF000929:Tyr-Ptase_nr_6]
protein tyrosine phosphatase, non-receptor type 6,SMART[760000168$SM00194:PTPc, 760000224$SM00252:SH2]
protein tyrosine phosphatase, non-receptor type 6,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001065$nucleus, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001261$protein phosphatase, 790001301$receptor, 790001304$repeat, 790001397$SH2 domain, 790001587$tyrosine-specific phosphatase]
protein tyrosine phosphatase, non-receptor type 6,UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850067660$chain:Tyrosine-protein phosphatase non-receptor type 6, 850105347$domain:SH2 1, 850105348$domain:SH2 2, 850105593$domain:Tyrosine-protein phosphatase, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
protein tyrosine phosphatase, receptor type, A,BIOCARTA[30000277$h_srcRPTPPathway:Activation of Src by Protein-tyrosine phosphatase alpha]
protein tyrosine phosphatase, receptor type, A,INTERPRO[450000210$IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450014489$IPR016130:Protein-tyrosine phosphatase, active site, 450014659$IPR016336:Receptor tyrosine-protein phosphatase, alpha/epsilon-type]
protein tyrosine phosphatase, receptor type, A,PIR_SUPERFAMILY[630002143$PIRSF002006:PTPR_alpha_epsilon, 630002144$PIRSF002006:receptor tyrosine-protein phosphatase, alpha/epsilon types, 630030965$PIRSF500808:receptor tyrosine-protein phosphatase alpha]
protein tyrosine phosphatase, receptor type, A,SMART[760000168$SM00194:PTPc]
protein tyrosine phosphatase, receptor type, A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001212$polymorphism, 790001261$protein phosphatase, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein, 790001587$tyrosine-specific phosphatase]
protein tyrosine phosphatase, receptor type, A,UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850056939$chain:Receptor-type tyrosine-protein phosphatase alpha, 850105594$domain:Tyrosine-protein phosphatase 1, 850105595$domain:Tyrosine-protein phosphatase 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
similar to THO complex 3; THO complex 3,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
similar to THO complex 3; THO complex 3,KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
similar to THO complex 3; THO complex 3,SMART[760000289$SM00320:WD40]
similar to THO complex 3; THO complex 3,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000988$mrna processing, 790000989$mrna splicing, 790000990$mRNA transport, 790001065$nucleus, 790001304$repeat, 790001339$rna-binding, 790001558$transport, 790001638$wd repeat]
similar to THO complex 3; THO complex 3,UP_SEQ_FEATURE[850064312$chain:THO complex subunit 3, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6]
similar to protein phosphatase 1, regulatory subunit 2; protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 4; chromosome 13 open reading frame 18,INTERPRO[450006453$IPR007062:Protein phosphatase inhibitor 2 (IPP-2)]
similar to protein phosphatase 1, regulatory subunit 2; protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 4; chromosome 13 open reading frame 18,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
similar to protein phosphatase 1, regulatory subunit 2; protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 4; chromosome 13 open reading frame 18,UP_SEQ_FEATURE[850073113$chain:Uncharacterized protein C13orf18, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
stromal antigen 3-like 4,INTERPRO[450012342$IPR013721:STAG]
stromal antigen 3-like 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
stromal antigen 3-like 4,UP_SEQ_FEATURE[850062323$chain:STAG3-like protein 4, 850117295$sequence variant]
survival of motor neuron 1, telomeric; survival of motor neuron 2, centromeric,INTERPRO[450002638$IPR002999:Tudor domain, 450009372$IPR010304:Survival motor neuron, 450016636$IPR018351:Tudor subgroup]
survival of motor neuron 1, telomeric; survival of motor neuron 2, centromeric,OMIM_DISEASE[520004600$Spinal muscular atrophy-1, 520004601$Spinal muscular atrophy-2, 520004602$Spinal muscular atrophy-3, 520004603$Spinal muscular atrophy-4]
survival of motor neuron 1, telomeric; survival of motor neuron 2, centromeric,PIR_SUPERFAMILY[630029255$PIRSF037678:survival motor neuron protein]
survival of motor neuron 1, telomeric; survival of motor neuron 2, centromeric,SMART[760000302$SM00333:TUDOR]
survival of motor neuron 1, telomeric; survival of motor neuron 2, centromeric,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000988$mrna processing, 790000989$mrna splicing, 790001015$neurodegeneration, 790001065$nucleus, 790001162$phosphoprotein, 790001339$rna-binding, 790001433$Spliceosome]
survival of motor neuron 1, telomeric; survival of motor neuron 2, centromeric,UP_SEQ_FEATURE[850063063$chain:Survival motor neuron protein, 850102580$compositionally biased region:Poly-Pro, 850105583$domain:Tudor, 850105852$helix, 850106258$modified residue, 850113855$region of interest:P1 (binding site for SIP1), 850113859$region of interest:P2 (binding site for SM B), 850114391$region of interest:Required for interaction with SYNCRIP, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
tetraspanin 1,INTERPRO[450000259$IPR000301:Tetraspanin, subgroup, 450016772$IPR018499:Tetraspanin, 450016776$IPR018503:Tetraspanin, conserved site]
tetraspanin 1,PIR_SUPERFAMILY[630002539$PIRSF002419:CD9 antigen]
tetraspanin 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000897$lysosome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
tetraspanin 1,UP_SEQ_FEATURE[850063970$chain:Tetraspanin-1, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
thioesterase superfamily member 4,INTERPRO[450006093$IPR006683:Thioesterase superfamily]
thioesterase superfamily member 4,SP_PIR_KEYWORDS[790000264$cell membrane, 790000267$cell projection, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
thioesterase superfamily member 4,UP_SEQ_FEATURE[850064186$chain:Thioesterase superfamily member 4, 850117295$sequence variant]
